Cotrimoxazole therapy ofToxoplasma gondii encephalitis in AIDS patients
- 70 Downloads
Twenty-four consecutive HIV-positive patients affected byToxoplasma gondii encephalitis received trimethoprim-sulfamethoxazole (cotrimoxazole) as acute-phase treatment. Two dosage regimens of cotrimoxazole were used: 40 mg/kg/day (12 patients) or 120 mg/kg/day (12 patients) of total compound (trimethoprim plus sulfamethoxazole). Clinical and radiological responses to treatment were evaluated, and the product-limit method for survival data analysis was used. Eighteen of 24 patients showed both a clinical and radiological response (75 % response rate). There were no differences in response rates between patients receiving the two dosage regimens of cotrimoxazole. Adverse reaction consisted of leukopenia (two cases) and skin rash (three cases) which led to the discontinuation of the drug in one case. These results suggest that a randomized, controlled clinical trial should be carried out comparing cotrimoxazole versus sulfadiazine-pyrimethamine in AIDS patients withToxoplasma gondii encephalitis.
Unable to display preview. Download preview PDF.
- 4.Terragna A, Rossolini A, Cellesi C, Figura N, Barbieri A: Activity of the combination trimethoprim-sulfa-methoxazole on experimental toxoplasmosis. Arzneimittel-Forschung (Drug Research) 1973, 23: 1328–1331.Google Scholar
- 7.Domart A, Robineau N, Carbon C: La toxoplasmose acquisé: une nouvelle chimiothérapie: l'association sulfaméthoxazole-triméthoprime. Nouvelle Presse Médicale 1973, 2: 321–322.Google Scholar
- 10.Nguyen BT, Stadtsbaeder S: Avenir thérapeutique du triméthoprime-sulfaméthoxazole dans la toxoplasmose. Presse Médicale 1983, 12: 331–333.Google Scholar
- 14.Lee ET: Statistical methods for survival data analysis. Lifetime Learning Publication, Belmont, California 1980.Google Scholar
- 15.Vollmer TL, Waldor MK, Steinman L, Conley FK: Depletion of T4+ lymphocytes with monoclonal antibody reactivates toxoplasmosis in the central nervous system: a model of superinfection in AIDS. Journal of Immunology 1987, 138: 3737–3741.Google Scholar
- 16.Canessa A, Pistoia V, Roncella S, Merli A, Melioli G, Terragna A, Ferrarini M: An in vitro model forToxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites. Journal of Immunology 1988, 140: 3580–3588.Google Scholar
- 20.Leport C, Raffi F, Matheron S, Katlama C, Regnier B, Saimot GA, Marche C, Vedrenne C, Vilde JL: Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. American Journal of Medicine 1988, 84: 94–100.CrossRefPubMedGoogle Scholar
- 22.De Hovitz JA, Johnson WD, Pape WJ: Cutaneous reactions to trimethoprim-sulfamethoxazole in Haitians. Annals of Internal Medicine 1985, 103: 479–480.Google Scholar